Viable CD34+ stem cell content of a cord blood graft: Which measurement performed before transplantation is most representative?

Transfusion

Volumn 44, Issue 4, 2004, Pages 547-554

  Van Haute, Inge ^a   Lootens, Nele ^b   De Smet, Saskia ^b   De Buck, Carine ^b   Verdegem, Linda ^b   Vanheusden, Katrien ^b   Pinxteren, Jef ^b   Vandekerckhove, Bart ^b  

^a BTC Oost Vlaanderen   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; CD34 ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; BLOOD VOLUME; CELL COUNT; CELL SUBPOPULATION; CELL VIABILITY; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MEASUREMENT; REPRODUCIBILITY; TECHNIQUE; TOTAL NUCLEATED CELL COUNT; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BLOOD CELL COUNT; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1842562922     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03254.x     Document Type: Article

References (24)

1. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101:4233-44.
2. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-43.
3. Gluckman E, Rocha V, Chastang C. Peripheral stem cells in bone marrow transplantation: cord blood stem cell transplantation. Baillieres Best Pract Res Clin Haematol 1999;12:279-92.
4. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
5. Lewis ID. Clinical and experimental uses of umbilical cord blood. Intern Med J 2002;32:601-9.
6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337: 373-81.
7. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
8. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-54.
9. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8.
10. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-37.
11. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992;89:2804-8.
12. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989;74:1563-70.
13. Noga SJ, Sutherland R. Current methods and new developments in graft evaluation. Cytotherapy 2000;2:389-90.
14. Keeney M, Sutherland DR. Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumeration. Cytotherapy 2000;2:395-402.
15. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
16. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994;87:825-31.
17. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
18. Rogers I, Sutherland DR, Holt D, et al. Human UC-cord blood banking: impact of blood volume, cell separation and cryopreservation on leucocyte and CD34+ cell recovery. Cytotherapy 2001;3:269-76.
19. Donaldson C, Armitage WJ, Laundy V, et al. Impact of obstetric factors on cord blood donation for transplantation. Br J Haemotol 1999;106:128-32.
20. Beaujean F, Bourhis JH, Bayle C, et al. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Bone Marrow Transplant 1998;22:1091-6.
21. Sputtek A, Jetter S, Hummel K, Kuhnl P. Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques. Beitr Infusionsther Transfusionsmed 1997;34: 79-83.
22. Wang SY, Ho CK, Chen PM, et al. Comparison of stem cell viability of bone marrow cryopreserved by two different methods. Cryobiology 1987;24:229-37.
23. Salesse S, Verfaillie CM. BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia. Mol Cancer Ther 2003;2:173-82.
24. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.